Stay updated on Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page’s footer revision/version number was updated from v3.5.2 to v3.5.3, reflecting a site build or release change rather than any modification to the clinical trial record.
    Difference
    0.0%
    Check dated 2026-04-25T18:39:46.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T13:33:05.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Padua, Italy, 35128 was replaced with Padova, Italy, 35128 in the Italy locations list.
    Difference
    0.0%
    Check dated 2026-04-04T05:47:08.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Location entry updated from Napoli, Italy, 80131 to Naples, Italy, 80131. Revision label updated to v3.5.0, replacing the previous v3.4.3 entry.
    Difference
    0.0%
    Check dated 2026-03-20T20:18:47.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T18:11:52.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The revision label updated from v3.4.1 to v3.4.2. No study details or results are affected.
    Difference
    0.0%
    Check dated 2026-02-13T12:39:12.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial page.